Literature DB >> 28156205

Metabolite and functional profile of patients with cervical spondylotic myelopathy.

Izabela Aleksanderek1,2, Todd K Stevens2, Sandy Goncalves1,2, Robert Bartha1,2, Neil Duggal1,3.   

Abstract

OBJECTIVE The goal of this study was to compare the recovery of neuronal metabolism and functional reorganization in the primary motor cortex (M1) between mild and moderate cervical spondylotic myelopathy (CSM) following surgical intervention. METHODS Twenty-eight patients with CSM underwent 3-T MRI scans that included spectroscopy and functional MRI, before surgery and 6 months postsurgery. The classification of severity was based on the modified Japanese Orthopaedic Association questionnaire. Mild and moderate myelopathy were defined by modified Japanese Orthopaedic Association scores > 12 of 18 (n = 15) and 9-12 (n = 13), respectively. Ten healthy control subjects underwent 2 MRI scans 6 months apart. Metabolite levels were measured in the M1 contralateral to the greater deficit side in patients with CSM and on both sides in the controls. Motor function was assessed using a right finger-tapping paradigm and analyzed with BrainVoyager QX. RESULTS Patients with mild CSM had a lower preoperative N-acetylaspartate to creatine (NAA/Cr) ratio compared with moderate CSM, suggesting mitochondrial dysfunction. Postsurgery, NAA/Cr in moderate CSM decreased to the levels observed in mild CSM. Preoperatively, patients with mild CSM had a larger volume of activation (VOA) in the M1 than those with moderate CSM. Postoperatively, the VOAs were comparable between the mild and moderate CSM groups and had shifted toward the primary sensory cortex. CONCLUSIONS The NAA/Cr ratio and VOA size in the M1 can be used to discriminate between mild and moderate CSM. Postsurgery, the metabolite profile of the M1 did not recover in either group, despite significant clinical improvement. The authors proposed that metabolic impairment in the M1 may trigger the recruitment of adjacent healthy cortex to achieve functional recovery.

Entities:  

Keywords:  BA = Brodmann area; COG = center of gravity; CSM = cervical spondylotic myelopathy; Cr = creatine; FDR = false discovery rate; M1 = primary motor cortex; MRS = MR spectroscopy; N-acetylaspartate; NAA = N-acetylaspartate; VOA = volume of activation; brain plasticity; cervical spondylotic myelopathy; fMRI = functional MRI; functional MRI; mJOA = modified Japanese Orthopaedic Association; magnetic resonance spectroscopy

Mesh:

Substances:

Year:  2017        PMID: 28156205     DOI: 10.3171/2016.9.SPINE151507

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  5 in total

1.  Neck disability in patients with cervical spondylosis is associated with altered brain functional connectivity.

Authors:  Langston T Holly; Chencai Wang; Davis C Woodworth; Noriko Salamon; Benjamin M Ellingson
Journal:  J Clin Neurosci       Date:  2019-08-13       Impact factor: 1.961

2.  A feasibility study of modified self-efficacy for the improvement of adverse emotions and quality of life in traumatic fracture patients.

Authors:  Yanbo Ma; Hongjing Wu; Yanting Wang; Leilei Guo
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Quantitative MR Markers in Non-Myelopathic Spinal Cord Compression: A Narrative Review.

Authors:  Jan Valošek; Petr Bednařík; Miloš Keřkovský; Petr Hluštík; Josef Bednařík; Alena Svatkova
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

4.  Compensatory brainstem functional and structural connectivity in patients with degenerative cervical myelopathy by probabilistic tractography and functional MRI.

Authors:  Chencai Wang; Azim Laiwalla; Noriko Salamon; Benjamin M Ellingson; Langston T Holly
Journal:  Brain Res       Date:  2020-09-17       Impact factor: 3.252

5.  In vivo Molecular Signatures of Cervical Spinal Cord Pathology in Degenerative Compression.

Authors:  Tomas Horak; Magda Horakova; Alena Svatkova; Zdenek Kadanka; Petr Kudlicka; Jan Valosek; Tomas Rohan; Milos Kerkovsky; Eva Vlckova; Zdenek Kadanka; Dinesh K Deelchand; Pierre-Gilles Henry; Josef Bednarik; Petr Bednarik
Journal:  J Neurotrauma       Date:  2021-11-01       Impact factor: 5.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.